Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Nutex Health Inc.CLNH · Entity 4803 | Director | May 11, 2020 | September 29, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Nutex Health Inc.
Report date May 11, 2020 · Filed September 29, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 349,652 |
Reported balance
After 2020-06-30 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2020-06-30 · Purchase · Acquired 31,034 · Balance 349,652 F1: (1) Does not include 30,000 options reported on Table II. |
| Common StockSEC Table I · non-derivative | Direct | 574,998 |
Reported balance
After 2020-07-13 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2020-07-13 · Purchase · Acquired 228,346 · Balance 574,998 F1: (1) Does not include 30,000 options reported on Table II. |
| Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.50 · Expires 2027-05-11 | Direct | 30,000 |
Reported balance
After 2020-05-11 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2020-05-11 · Grant · Acquired 30,000 · Balance 30,000 |
Filing footnotes · ownership attribution and instrument terms
F1: (1) Does not include 30,000 options reported on Table II.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 13, 2020 Filed Sep 29, 2020 16:15 UTC | Nutex Health Inc. CLNH · Entity 4803 | PurchaseCommon Stock | 228,346 | $179,800.00 | $41,056,610,800.00 |
DisclosureSEC source: 0001793452-20-000001 · primary_doc.xml · nonDerivative · entry 2 Margolin Jacob · CIK 0001793452 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 574,998 F1 · balance_after: (1) Does not include 30,000 options reported on Table II. Read SEC document |
| June 30, 2020 Filed Sep 29, 2020 16:15 UTC | Nutex Health Inc. CLNH · Entity 4803 | PurchaseCommon Stock | 31,034 | $45,000.00 | $1,396,530,000.00 |
DisclosureSEC source: 0001793452-20-000001 · primary_doc.xml · nonDerivative · entry 1 Margolin Jacob · CIK 0001793452 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 349,652 F1 · balance_after: (1) Does not include 30,000 options reported on Table II. Read SEC document |
| May 11, 2020 Filed Sep 29, 2020 16:15 UTC | Nutex Health Inc. CLNH · Entity 4803 | GrantDirector Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001793452-20-000001 · primary_doc.xml · derivative · entry 3 Margolin Jacob · CIK 0001793452 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2027-05-11 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.